| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.36 | 0.02 |